Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1986 1
1987 4
1988 23
1989 21
1990 19
1991 18
1992 19
1993 38
1994 25
1995 30
1996 29
1997 35
1998 29
1999 38
2000 42
2001 39
2002 53
2003 46
2004 44
2005 58
2006 65
2007 48
2008 44
2009 51
2010 66
2011 67
2012 81
2013 86
2014 156
2015 176
2016 233
2017 223
2018 225
2019 247
2020 280
2021 193
Text availability
Article attribute
Article type
Publication date

Search Results

2,560 results
Results by year
Filters applied: . Clear all
Page 1
Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment.
Duma N, Santana-Davila R, Molina JR. Duma N, et al. Mayo Clin Proc. 2019 Aug;94(8):1623-1640. doi: 10.1016/j.mayocp.2019.01.013. Mayo Clin Proc. 2019. PMID: 31378236 Review.
Lung cancer remains the leading cause of cancer deaths in the United States. ...The National Lung Screening Trial found a lung cancer mortality benefit of 20% and a 6.7% decrease in all-cause mortality with the use of low-dose chest compu
Lung cancer remains the leading cause of cancer deaths in the United States. ...The National Lung Screening Tria
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.
Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Molina JR, et al. Mayo Clin Proc. 2008 May;83(5):584-94. doi: 10.4065/83.5.584. Mayo Clin Proc. 2008. PMID: 18452692 Free PMC article. Review.
Lung cancer is the leading cause of cancer-related mortality not only in the United States but also around the world. ...Non-small cell lung cancer accounts for 85% of all lung cancer cases in the United States. ...
Lung cancer is the leading cause of cancer-related mortality not only in the United States but also around the world. .
Current Diagnosis and Management of Small-Cell Lung Cancer.
Wang S, Zimmermann S, Parikh K, Mansfield AS, Adjei AA. Wang S, et al. Mayo Clin Proc. 2019 Aug;94(8):1599-1622. doi: 10.1016/j.mayocp.2019.01.034. Mayo Clin Proc. 2019. PMID: 31378235 Review.
Small-cell lung cancer (SCLC) is an aggressive disease with distinct pathological, clinical, and molecular characteristics from non-small-cell lung cancer. ...
Small-cell lung cancer (SCLC) is an aggressive disease with distinct pathological, clinical, and molecular characteristics fro …
Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Gould MK, Donington J, Lynch WR, Mazzone PJ, Midthun DE, Naidich DP, Wiener RS. Gould MK, et al. Chest. 2013 May;143(5 Suppl):e93S-e120S. doi: 10.1378/chest.12-2351. Chest. 2013. PMID: 23649456 Free PMC article. Review.
METHODS: We updated prior literature reviews, synthesized evidence, and formulated recommendations by using the methods described in the "Methodology for Development of Guidelines for Lung Cancer" in the American College of Chest Physicians Lung Cancer
METHODS: We updated prior literature reviews, synthesized evidence, and formulated recommendations by using the methods described in the "Me …
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer.
Yatabe Y, Dacic S, Borczuk AC, Warth A, Russell PA, Lantuejoul S, Beasley MB, Thunnissen E, Pelosi G, Rekhtman N, Bubendorf L, Mino-Kenudson M, Yoshida A, Geisinger KR, Noguchi M, Chirieac LR, Bolting J, Chung JH, Chou TY, Chen G, Poleri C, Lopez-Rios F, Papotti M, Sholl LM, Roden AC, Travis WD, Hirsch FR, Kerr KM, Tsao MS, Nicholson AG, Wistuba I, Moreira AL. Yatabe Y, et al. J Thorac Oncol. 2019 Mar;14(3):377-407. doi: 10.1016/j.jtho.2018.12.005. Epub 2018 Dec 18. J Thorac Oncol. 2019. PMID: 30572031 Free PMC article.
Also, pathologists must be aware of many interpretation pitfalls, and the use of IHC should be efficient to spare the tissue for molecular testing. The International Association for the Study of Lung Cancer Pathology Committee received questions on practical applica …
Also, pathologists must be aware of many interpretation pitfalls, and the use of IHC should be efficient to spare the tissue for molecular t …
Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective.
Dai J, Yang P, Cox A, Jiang G. Dai J, et al. Oncotarget. 2017 Mar 14;8(11):18513-18524. doi: 10.18632/oncotarget.14505. Oncotarget. 2017. PMID: 28061470 Free PMC article. Review.
COPD confers a higher risk for lung cancer development, but available chemopreventive measures remain rudimentary. ...COPD-associated lung cancer presents distinct clinical features. Treatment for lung cancer coexisting with COPD is chall …
COPD confers a higher risk for lung cancer development, but available chemopreventive measures remain rudimentary. ...COPD-ass …
Neoadjuvant Immunotherapy for NSCLC: Current Concepts and Future Approaches.
Uprety D, Mandrekar SJ, Wigle D, Roden AC, Adjei AA. Uprety D, et al. J Thorac Oncol. 2020 Aug;15(8):1281-1297. doi: 10.1016/j.jtho.2020.05.020. Epub 2020 Jun 6. J Thorac Oncol. 2020. PMID: 32522713
Lung cancer is the leading cause of cancer-related deaths worldwide. ...
Lung cancer is the leading cause of cancer-related deaths worldwide. ...
Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer.
Morrison EJ, Novotny PJ, Sloan JA, Yang P, Patten CA, Ruddy KJ, Clark MM. Morrison EJ, et al. Clin Lung Cancer. 2017 Sep;18(5):497-503. doi: 10.1016/j.cllc.2017.02.008. Epub 2017 Mar 2. Clin Lung Cancer. 2017. PMID: 28412094
OBJECTIVES: Lung cancer is associated with a greater symptom burden than other cancers, yet little is known about the prevalence of emotional problems and how emotional problems may be related to the physical symptom burden and quality of life in newly diagnosed pat …
OBJECTIVES: Lung cancer is associated with a greater symptom burden than other cancers, yet little is known about the prevalen …
Emerging therapeutic agents for advanced non-small cell lung cancer.
Chen R, Manochakian R, James L, Azzouqa AG, Shi H, Zhang Y, Zhao Y, Zhou K, Lou Y. Chen R, et al. J Hematol Oncol. 2020 May 24;13(1):58. doi: 10.1186/s13045-020-00881-7. J Hematol Oncol. 2020. PMID: 32448366 Free PMC article. Review.
Advanced non-small cell lung cancer (NSCLC) is the most common type of lung cancer, with a poor prognosis and no known cure. ...
Advanced non-small cell lung cancer (NSCLC) is the most common type of lung cancer, with a poor prognosis and no …
Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies.
Wang J, Liu Q, Yuan S, Xie W, Liu Y, Xiang Y, Wu N, Wu L, Ma X, Cai T, Zhang Y, Sun Z, Li Y. Wang J, et al. Sci Rep. 2017 Aug 21;7(1):8371. doi: 10.1038/s41598-017-07737-0. Sci Rep. 2017. PMID: 28827732 Free PMC article. Review.
No significant associations with lung cancer risk were found for other 150 variants in 98 genes; however, seven variants demonstrated strong cumulative evidence. Our findings provided the most updated summary of genetic risk effects on lung cancer and …
No significant associations with lung cancer risk were found for other 150 variants in 98 genes; however, seven variants demon …
2,560 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page